← Open Payments lookup

RASHIDAT AKINSANYA: Open Payments

NPI 1790126670 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$535 in 23 payments from 6 companies in 2025. Trend: 2023 $732 · 2024 $532 · 2025 $535

Food & beverage: $535
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$216
ABBVIE INC.7$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
E.R. Squibb & Sons, L.L.C.2$33
Lundbeck LLC2$31
Alkermes, Inc.1$21

Products named: INGREZZA, VRAYLAR, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across MD — which companies pay providers there.